Experimental Ebola Treatments Bypassing Usual Regulatory Hurdles

Experimental Ebola treatments are moving with lightning speed through a regulatory process that, for most drugs, can take years. The urgency of the lethal epidemic in three West African countries - Guinea, Liberia and Sierra Leone - means a number of promising treatments are bypassing the usual hurdles toward approval. Before a new drug gets the green light from U.S. regulators, researchers are required to conduct in-depth clinical trials on people to demonstrate the...

Read complete article

~	UN rights experts urge Iran to immediately release British-Iranian citizen after fresh charges

~	In Blaustein lecture, UN rights chief rebukes notion that multilateralism is a threat in today's world

~	In Blaustein lecture, UN rights chief rebukes notion that multilateralism is a threat in today's world

~	In Balustein lecture, UN rights chief rebukes notion that multilateralism is a threat in today's world

~	Strong civil society can push back against 'major attack' on human rights, says senior UN rights official

~	In Balustein lecture, UN rights chief rebukes notion that multilateralism is a 'threat' in today's world

~	Iran: UN rights experts urge country to halt imminent execution of juvenile Amirhossein Pourjafar

~	UN rights experts urge Iran to halt imminent execution of juvenile Amirhossein Pourjafar

~	General Assembly elects new members to UN Human Rights Council

~	UN General Assembly elects new members to the Human Rights Council